AWM
KURA icon

Avior Wealth Management’s Kura Oncology KURA Stock Holding History

Avior Wealth Management’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-14
Closed -$298 – 3041
2024
Q1 		$298 Buy
+14
New +$272 ﹤0.01% 2727
2020
Q1 		– Sell
-100
Closed -$1K – 841
2019
Q4 		$1K Hold
100
– – ﹤0.01% 754
2019
Q3 		$1K Buy
100
+50
+100% +$890 ﹤0.01% 730
2019
Q2 		$1K Hold
50
– – ﹤0.01% 790
2019
Q1 		$0 Hold
50
– – ﹤0.01% 684
2018
Q4 		$0 Sell
50
-250
-83% -$3.31K ﹤0.01% 736
2018
Q3 		$5K Hold
300
– – ﹤0.01% 634
2018
Q2 		$5K Hold
300
– – ﹤0.01% 655
2018
Q1 		$6K Buy
300
+250
+500% +$4.87K ﹤0.01% 623
2017
Q4 		$1K Hold
50
– – ﹤0.01% 743
2017
Q3 		$1K Sell
50
-350
-88% -$3.29K ﹤0.01% 479
2017
Q2 		$4K Buy
+400
New +$3.64K ﹤0.01% 379

Other funds holding KURA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Avior Wealth Management's KURA Position: Q2 2024 in Review

Avior Wealth Management sold out of Kura Oncology (KURA) in Q2 2024, closing a stake of 14 shares — an estimated $298 sold.

Avior Wealth Management first reported a position in KURA in Q2 2017 and held it in 12 quarters. The position peaked at $6K in Q1 2018. 174 funds tracked by Wall St. Rank hold KURA as of Q2 2024.

  • Avior Wealth Management reported no remaining Kura Oncology position as of Q2 2024 after selling out during the quarter.
  • Avior Wealth Management sold 14 Kura Oncology shares in Q2 2024, an estimated $298.
  • Avior Wealth Management first reported a position in Kura Oncology in Q2 2017 and held it in 12 quarters.
  • Avior Wealth Management's Kura Oncology position peaked at $6K in Q1 2018.
  • 174 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2024.

Based on Avior Wealth Management's 13F filing for Q2 2024, filed 13 Aug 2024.